eZine

Increase Your Risk of Heart Disease With Lipitor and Pravachol

Results of a new study comparing the effectiveness of Pfizer Inc.,’s Lipitor with Pravachol, made by Bristol-Myers Squibb, was recently published in the New York Times. The study details the clinical observation that Lipitor was significantly more effective than Pravachol in lowering patient’s LDL cholesterol levels. However, the study did not comment on the overall […]

This article is only available to members. Please Login or register.
Exit mobile version